Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Hematology Association
Pharma
Inconsistent survival data dent Roche's Columvi win in 2L DLBCL
An exploratory analysis showed that Columvi’s overall survival benefit appeared to be driven entirely by patients outside the U.S. and Europe.
Angus Liu
Jun 16, 2024 5:32pm
J&J's Darzalex branches out beyond myeloma with amyloidosis win
Jun 13, 2020 2:30am
AbbVie, Roche cement Venclexta's place in AML with survival win
Jun 13, 2020 2:30am
